Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 6373506, 11 pages
http://dx.doi.org/10.1155/2016/6373506
Research Article

Nonessential Role for the NLRP1 Inflammasome Complex in a Murine Model of Traumatic Brain Injury

The Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Duck Pond Drive, Blacksburg, VA 24061, USA

Received 8 January 2016; Revised 8 March 2016; Accepted 24 March 2016

Academic Editor: Luc Vallières

Copyright © 2016 Thomas Brickler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Rivest, “Regulation of innate immune responses in the brain,” Nature Reviews Immunology, vol. 9, no. 6, pp. 429–439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Loane and K. R. Byrnes, “Role of microglia in neurotrauma,” Neurotherapeutics, vol. 7, no. 4, pp. 366–377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Chen, J. D. Pickard, and N. G. Harris, “Time course of cellular pathology after controlled cortical impact injury,” Experimental Neurology, vol. 182, no. 1, pp. 87–102, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Martinon, K. Burns, and J. Tschopp, “The Inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β,” Molecular Cell, vol. 10, no. 2, pp. 417–426, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Chen and B. Sun, “Negative regulation of NLRP3 inflammasome signaling,” Protein & Cell, vol. 4, no. 4, pp. 251–258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. V. A. K. Rathinam, S. K. Vanaja, and K. A. Fitzgerald, “Regulation of inflammasome signaling,” Nature Immunology, vol. 13, no. 4, pp. 333–342, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Minkiewicz, J. P. de Rivero Vaccari, and R. W. Keane, “Human astrocytes express a novel NLRP2 inflammasome,” Glia, vol. 61, no. 7, pp. 1113–1121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. H.-D. Liu, W. Li, Z.-R. Chen et al., “Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model,” Neurochemical Research, vol. 38, no. 10, pp. 2072–2083, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. P. de Rivero Vaccari, G. Lotocki, O. F. Alonso, H. M. Bramlett, W. D. Dietrich, and R. W. Keane, “Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 7, pp. 1251–1261, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Jha, S. Y. Srivastava, W. J. Brickey et al., “The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18,” The Journal of Neuroscience, vol. 30, no. 47, pp. 15811–15820, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Alboni, C. Montanari, C. Benatti et al., “Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells,” Brain, Behavior, and Immunity, vol. 40, pp. 85–94, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. S. J. Crampton, L. M. Collins, A. Toulouse, Y. M. Nolan, and G. W. O'Keeffe, “Exposure of foetal neural progenitor cells to IL-1β impairs their proliferation and alters their differentiation—a role for maternal inflammation?” Journal of Neurochemistry, vol. 120, no. 6, pp. 964–973, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Miyoshi, K. Obata, T. Kondo, H. Okamura, and K. Noguchi, “Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury,” The Journal of Neuroscience, vol. 28, no. 48, pp. 12775–12787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. E. Adamczak, J. P. de Rivero Vaccari, G. Dale et al., “Pyroptotic neuronal cell death mediated by the AIM2 inflammasome,” Journal of Cerebral Blood Flow and Metabolism, vol. 34, no. 4, pp. 621–629, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Bergsbaken, S. L. Fink, and B. T. Cookson, “Pyroptosis: host cell death and inflammation,” Nature Reviews Microbiology, vol. 7, no. 2, pp. 99–109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. W.-H. Zhang, X. Wang, M. Narayanan et al., “Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 16012–16017, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Kovarova, P. R. Hesker, L. Jania et al., “NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice,” The Journal of Immunology, vol. 189, no. 4, pp. 2006–2016, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Mariathasan, K. Hewton, D. M. Monack et al., “Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf,” Nature, vol. 430, no. 6996, pp. 213–218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Baumann, L. Travieso, D. J. Liebl, and M. H. Theus, “Pronounced hypoxia in the subventricular zone following traumatic brain injury and the neural stem/progenitor cell response,” Experimental Biology and Medicine, vol. 238, no. 7, pp. 830–841, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. H. Theus, J. Ricard, J. R. Bethea, and D. J. Liebl, “EphB3 limits the expansion of neural progenitor cells in the subventricular zone by regulating p53 during homeostasis and following traumatic brain injury,” Stem Cells, vol. 28, no. 7, pp. 1231–1242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. H. Theus, J. Ricard, S. J. Glass, L. G. Travieso, and D. J. Liebl, “EphrinB3 blocks EphB3 dependence receptor functions to prevent cell death following traumatic brain injury,” Cell Death & Disease, vol. 5, no. 5, Article ID e1207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. R. J. Hamm, B. R. Pike, D. M. O'Dell, B. G. Lyeth, and L. W. Jenkins, “The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury,” Journal of Neurotrauma, vol. 11, no. 2, pp. 187–196, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Gris, Z. Ye, H. A. Iocca et al., “NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses,” The Journal of Immunology, vol. 185, no. 2, pp. 974–981, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. I. C. Allen, E. M. Tekippe, R.-M. T. Woodford et al., “The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer,” The Journal of Experimental Medicine, vol. 207, no. 5, pp. 1045–1056, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. I. C. Allen, J. E. Wilson, M. Schneider et al., “NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling,” Immunity, vol. 36, no. 5, pp. 742–754, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. T. M. Williams, R. A. Leeth, D. E. Rothschild et al., “Caspase-11 attenuates gastrointestinal inflammation and experimental colitis pathogenesis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 308, no. 2, pp. G139–G150, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. J. H. Pedra, S. L. Cassel, and F. S. Sutterwala, “Sensing pathogens and danger signals by the inflammasome,” Current Opinion in Immunology, vol. 21, no. 1, pp. 10–16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. E. Natale, F. Ahmed, I. Cernak, B. Stoica, and A. I. Faden, “Gene expression profile changes are commonly modulated across models and species after traumatic brain injury,” Journal of Neurotrauma, vol. 20, no. 10, pp. 907–927, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Kupershmidt, Q. J. Su, A. Grewal et al., “Ontology-based meta-analysis of global collections of high-throughput public data,” PLoS ONE, vol. 5, no. 9, Article ID e13066, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. H. S. Levin, “Cognitive function outcomes after traumatic brain injury,” Current Opinion in Neurology, vol. 11, no. 6, pp. 643–646, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. R. J. Hamm, C. E. Dixon, D. M. Gbadebo et al., “Cognitive deficits following traumatic brain injury produced by controlled cortical impact,” Journal of Neurotrauma, vol. 9, no. 1, pp. 11–20, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. E. D. Hall, P. G. Sullivan, T. R. Gibson, K. M. Pavel, B. M. Thompson, and S. W. Scheff, “Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury,” Journal of Neurotrauma, vol. 22, no. 2, pp. 252–265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. J. G. Walsh, D. A. Muruve, and C. Power, “Inflammasomes in the CNS,” Nature Reviews Neuroscience, vol. 15, no. 2, pp. 84–97, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Fan, P. R. Young, F. C. Barone, G. Z. Feuerstein, D. H. Smith, and T. K. McIntosh, “Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain,” Brain Research Molecular Brain Research, vol. 30, no. 1, pp. 125–130, 1995. View at Google Scholar
  35. C. D. Mills, B. C. Hains, K. M. Johnson, and C. E. Hulsebosch, “Strain and model differences in behavioral outcomes after spinal cord injury in rat,” Journal of Neurotrauma, vol. 18, no. 8, pp. 743–756, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. T. M. Williams, R. A. Leeth, D. E. Rothschild et al., “The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis,” Journal of Immunology, vol. 194, no. 7, pp. 3369–3380, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. I. C. Allen, C. B. Moore, M. Schneider et al., “NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways,” Immunity, vol. 34, no. 6, pp. 854–865, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. I. C. Allen, M. A. Scull, C. B. Moore et al., “The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA,” Immunity, vol. 30, no. 4, pp. 556–565, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. R. M. Lechan, R. Toni, B. D. Clark et al., “Immunoreactive interleukin-1β localization in the rat forebrain,” Brain Research, vol. 514, no. 1, pp. 135–140, 1990. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Boutin, I. Kimber, N. J. Rothwell, and E. Pinteaux, “The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain,” Molecular Neurobiology, vol. 27, no. 3, pp. 239–248, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Shechter, A. London, C. Varol et al., “Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice,” PLoS Medicine, vol. 6, no. 7, Article ID e1000113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. P. G. Popovich and E. E. Longbrake, “Can the immune system be harnessed to repair the CNS?” Nature Reviews Neuroscience, vol. 9, no. 6, pp. 481–493, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. S. M. Allan, P. J. Tyrrell, and N. J. Rothwell, “Interleukin-1 and neuronal injury,” Nature Reviews Immunology, vol. 5, no. 8, pp. 629–640, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Brough, P. J. Tyrrell, and S. M. Allan, “Regulation of interleukin-1 in acute brain injury,” Trends in Pharmacological Sciences, vol. 32, no. 10, pp. 617–622, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Yamasaki, N. Matsuura, H. Shozuhara et al., “Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats,” Stroke, vol. 26, no. 4, pp. 676–681, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. J. K. Relton and N. J. Rothwell, “Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat,” Brain Research Bulletin, vol. 29, no. 2, pp. 243–246, 1992. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Hara, R. M. Friedlander, V. Gagliardini et al., “Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 5, pp. 2007–2012, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Boutin, R. A. LeFeuvre, R. Horai, M. Asano, Y. Iwakura, and N. J. Rothwell, “Role of IL-1alpha and IL-1beta in ischemic brain damage,” The Journal of Neuroscience, vol. 21, no. 15, pp. 5528–5534, 2001. View at Google Scholar · View at Scopus
  49. H. C. A. Emsley, C. J. Smith, R. F. Georgiou et al., “A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 10, pp. 1366–1372, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Namas, A. Ghuma, L. Hermus et al., “The acute inflammatory response in trauma/hemorrhage and traumatic brain injury: current state and emerging prospects,” Libyan Journal of Medicine, vol. 4, no. 3, pp. 97–103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Fan, P. R. Young, F. C. Barone, G. Z. Feuerstein, D. H. Smith, and T. K. McIntosh, “Experimental brain injury induces differential expression of tumor necrosis factor-α mRNA in the CNS,” Molecular Brain Research, vol. 36, no. 2, pp. 287–291, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Kita, L. Liu, N. Tanaka, and Y. Kinoshita, “The expression of tumor necrosis factor-α in the rat brain after fluid percussive injury,” International Journal of Legal Medicine, vol. 110, no. 6, pp. 305–311, 1997. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Shohami, M. Novikov, R. Bass, A. Yamin, and R. Gallily, “Closed head injury triggers early production of TNFα and IL-6 by brain tissue,” Journal of Cerebral Blood Flow and Metabolism, vol. 14, no. 4, pp. 615–619, 1994. View at Publisher · View at Google Scholar · View at Scopus
  54. V. Taupin, S. Toulmond, A. Serrano, J. Benavides, and F. Zavala, “Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand,” Journal of Neuroimmunology, vol. 42, no. 2, pp. 177–185, 1993. View at Publisher · View at Google Scholar · View at Scopus
  55. M. E. Cinat, K. Waxman, G. A. Granger, W. Pearce, C. Annas, and K. Daughters, “Trauma causes sustained elevation of soluble tumor necrosis factor receptors,” Journal of the American College of Surgeons, vol. 179, no. 5, pp. 529–537, 1994. View at Google Scholar · View at Scopus
  56. T. Hensler, S. Sauerland, B. Bouillon et al., “Association between injury pattern of patients with multiple injuries and circulating levels of soluble tumor necrosis factor receptors, interleukin-6 and interleukin-10, and polymorphonuclear neutrophil elastase,” Journal of Trauma-Injury Infection & Critical Care, vol. 52, no. 5, pp. 962–970, 2002. View at Publisher · View at Google Scholar
  57. C. Martin, C. Boisson, M. Haccoun, L. Thomachot, and J.-L. Mege, “Patterns of cytokine evolution (tumor necrosis factor-α and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma,” Critical Care Medicine, vol. 25, no. 11, pp. 1813–1819, 1997. View at Publisher · View at Google Scholar · View at Scopus
  58. R. K. Narayan, M. E. Michel, B. Ansell et al., “Clinical trials in head injury,” Journal of Neurotrauma, vol. 19, no. 5, pp. 503–557, 2002. View at Publisher · View at Google Scholar · View at Scopus